Additionally, several research reported GSEC could promote the malignant process of triple-negative breast cancer and hepatocellular carcinoma via the GSEC/miR-202-5p/AXL axis and the GSEC/miR-101-3p/SNX16/PAPOLG axis38,39, respectively. The gene discussed is SNX16; the disease is hepatocellular carcinoma.